Skip to main content
SpringerLink
Log in

Health Economics

  • Chapter
  • First Online:
International Manual of Oncology Practice

  • 762 Accesses

Abstract

Health Care Costs have been increasing above Economic Growth in most of the countries of the world in the last decade, creating a significant challenge for the financing and incorporation of new technologies. Governments and Private Health Insurance Companies face consumer’’s increasing dissatisfaction with the Health Care that is delivered. A clear understanding of the critical clinical outcomes and of the efficiency of the Health Care Systems does not exist. The evaluation of new technologies and the decisions about their incorporation are done without taking into consideration the available budget and the opportunity costs. It is not simple for Health Care Professionals and Managers to see and measure the opportunity costs involved in the decisions that are made by them.

Health Economics is a Social Science that has the objective of giving Health Care Professionals and Managers the ability to navigate in this complex Health Care world and help them make the best choices and decisions for patients and society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Begg D et al (2014) Economics, 11th edn, Chapter 1

    Google Scholar 

  2. Folland G, Stano M (2017) The economics of health and health care, 8th edn, Chapter 1. Pearson Education, Inc., Upper Saddle River, p 12

    Google Scholar 

  3. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, pp 25–26

    Google Scholar 

  4. Folland G, Stano M (2017) The economics of health and health care, 8th edn, Chapter 1. Pearson Education, Inc., Upper Saddle River, pp 4–5

    Google Scholar 

  5. Maynard A, Kanavos P (2000) Health economics: an evolving paradigm. Health Econ 9:183–190

    Google Scholar 

  6. Lomas J et al (2018) Resolving the “Cost-Effective but Unaffordable” paradox: estimating the health opportunity costs of nonmarginal budget impacts. Value Health 21:266–275

    Article  Google Scholar 

  7. Folland G, Stano M (2017) The economics of health and health care, 8th, Chapter 2, Practice with supply and demand. Pearson Education, Inc., Upper Saddle River, pp 30–34

    Google Scholar 

  8. Porter M (2010) What is Value in Health Care? N Engl J Med 363:2477–2481

    Google Scholar 

  9. Porter M (2010) Measuring health outcomes: the outcomes hierarchy. New Eng J Med 363:2477–2481

    Google Scholar 

  10. Porter M (2008) Defining and introducing value in health care. In: Evidence-based medicine and the changing nature of health care: 2007 IOM Annual Meeting Summary. The National Academies Press, Washington, DC, pp 161–172

    Google Scholar 

  11. Feely TW, Fly HS, Albright H, Walters R, Burke TW (2010) A method for defining value in healthcare. Using cancer care as a model. J Healthc Manag 55(6):399–412

    Article  Google Scholar 

  12. Porter ME, Teisberg EO (2006) Redefining health care. Harvard Business School Press, Boston

    Google Scholar 

  13. Papanicolas I et al (2018) Health care spending in the United States and other high-income countries. JAMA 319(10):1024–1039

    Article  Google Scholar 

  14. http://www.aon.com/unitedkingdom/employee-benefits/news/articles/medical-cost-increases-2016.jsp

  15. https://bmo.bmiresearch.com/data/datatool _ BMI research, A Fitch Group Company _ Data Tool

  16. Keehan S (2017) National health expenditure projections, 2016–25: price increases, aging push sector to 20 percent of economy. Health Aff 36(3):553–563. https://doi.org/10.1377/hlthaff.2016.1627

    Article  Google Scholar 

  17. https://www.oecd-ilibrary.org/social-issues-migration-health/data/oecd-health-statistics_health-data-en

  18. www.onlinestatbook.com/2/regression/regression.html

  19. https://www.statisticshowto.datasciencecentral.com/probability-and-statistics/coefficient-of-determination-r-squared/

  20. https://www.who.int/social_determinants/en/

  21. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, p 11

    Google Scholar 

  22. https://euroqol.org/eq-5d-instruments/

  23. https://euroqol.org/wp-content/uploads/2016/10/Sample_UK__English__EQ-5D-5L_Paper_Self_complete_v1.0__ID_24700.pdf

  24. Stolk E (2019) Overview, update, and lessons learned from the International EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value Health 22:23–30

    Article  Google Scholar 

  25. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, pp 2–3

    Google Scholar 

  26. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, pp 219–232

    Google Scholar 

  27. Bertram MY et al (2016) Cost-effectiveness thresholds: pros and cons. Bull World Health Organ 94:924–930

    Article  Google Scholar 

  28. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, pp 79–83

    Google Scholar 

  29. Leech AA et al (2018) Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies. Value Health 21:759–761

    Article  Google Scholar 

  30. Drummond M et al (2015) Methods for the economic evaluation of health care programmes, 4th edn. Oxford University Press, Oxford/New York, pp 83–94

    Google Scholar 

  31. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M (2015) Methods for the estimation of the NICE cost-effectiveness threshold. Health Technol Assess 19(14):1–503. https://doi.org/10.3310/hta19140

    Article  PubMed  PubMed Central  Google Scholar 

  32. Folland G, Stano M (2017) The economics of health and health care, 8th edn, Chapter 1. Routledge, London, p 102

    Book  Google Scholar 

  33. Marseille E (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 93:118–124. https://doi.org/10.2471/BLT.14.138206

    Article  PubMed  Google Scholar 

  34. Lack of health care is a waste of human capital: 5 ways to achieve universal health coverage by 2030. World Bank. December 7, 2018. https://www.worldbank.org/en/news/immersive-story/2018/12/07/lack-of-health-care-is-a-waste-of-human-capital-5-ways-to-achieve-universal-health-coverage-by-2030. Accessed on 13 Dec 2018

  35. https://www.fda.gov/ScienceResearch/SpecialTopics/RealWorldEvidence/default.htm

  36. Gotzsche P (1989) Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Control Clin Trials 10:31–56

    Article  CAS  Google Scholar 

  37. Roland M, Torgerson D (1998) Understanding controlled trials: what are pragmatic trials? BMJ 316:285

    Article  CAS  Google Scholar 

  38. Webb P, Bain C (2011) Essential epidemiology. An introduction for students and health professionals, 2nd edn. University Press, Cambridge, pp 230–232

    Google Scholar 

  39. https://www.england.nhs.uk/healthcare-science/personalisedmedicine/

  40. Bland JM, Altman DG (1998) Survival probabilities (the Kaplan-Meier method). BMJ 317(7172):1572. www.bmj.com/content/317/7172/1572.full

    Article  CAS  Google Scholar 

  41. Manary MP et al (2013) The patient experience and health outcomes. NEJM 368:201–203

    Article  CAS  Google Scholar 

  42. https://www.ibm.com/industries/healthcare/datadilemma. Accessed on 20 Oct 2018

  43. Porter M (2010) What is value in health care? N Engl J Med 363:2477–2481

    Article  CAS  Google Scholar 

Download references

Acknowledgement

We would like to acknowledge Dr. Fernando Meton, COI Institute, Rio de Janeiro, Brazil

Author information

Authors and Affiliations

  1. Health Economics Programme, University of York, York, UK

    Nelson Teich

  2. Health Economist, Rio de Janeiro, Brazil

    Vanessa Teich

Authors
  1. Nelson Teich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vanessa Teich
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Medical Oncology, Federal University of São Paulo (UNIFESP) & Hospital Israelita Albert Einstein, São Paulo, Brazil, Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal

    Ramon Andrade De Mello

  2. Oncology Department, Henry Dunant Hospital Center, Athens, Greece

    Giannis Mountzios

  3. Department of Biomedical Sciences and Medicine, Universidade do Algarve, Faro, Portugal

    Álvaro A. Tavares

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Teich, N., Teich, V. (2019). Health Economics. In: De Mello, R., Mountzios, G., Tavares, Á. (eds) International Manual of Oncology Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-16245-0_8

Download citation

Publish with us

Policies and ethics

Search

Navigation